Is dual site better than single site atrial pacing in the prevention of atrial fibrillation?

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 12 I, 2000, Pages 2101-2107

  Leclercq, Jean François ^a   De Sisti, Antonio ^a   Fiorello, Pierre ^a   Halimi, Franck ^a   Manot, Stephanie ^a   Attuel, Patrick ^a  

^a Centre Chirurgical Val d'Or   (France)

Author keywords

Atrial fibrillation; Atrial pacing; Dual site atrial pacing; Sick sinus syndrome

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE;

EID: 0034492240     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb00783.x     Document Type: Article

References (30)

1. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality
2. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome
3. Natural history of sinus node disease treated with atrial pacing in 213 patients: Implications for selection of stimulation mode
4. Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome
5. Arrhythmia prevention by permanent atrial resynchronization in advanced interatrial block
6. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
7. Biatrial synchronous pacing for atrial arrhythmia prevention: The SYMBIAPACE Study
8. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation
9. Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate
10. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases
11. DDD pacing: An effective treatment modality for recurrent atrial arrhythmias
12. Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation
13. Coronary sinus pacing prevents induction of atrial fibrillation
14. Effects of different atrial pacing modes on atrial electrophysiology
15. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation
16. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhytmia
17. Cardiac pacing for terminating and preventing atrial flutter and fibrillation
18. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single and dual-site right atrial pacing for arrhythmia prevention
19. Atrial excitability and conduction in patients with interatrial conduction defects
20. Relationship between atrial conduction defects and fractioned atrial endocardial electrograms in patients with sick sinus syndrome
21. Clinical and electrocardiographic predictors of recurrent atrial fibrillation
22. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences
23. Electrophysiological characteristics of the atrium in sinus node dysfunction with and without post-pacing atrial fibrillation
24. Relation between widening of the fragmented atrial activity zone and atrial fibrillation
25. Prolonged and fractionated atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome
26. Electrophysiological characteristics of the atrium in sinus node dysfunction: Atrial refractoriness and conduction characteristics
27. Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation
28. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
29. Problems in pharmacological evaluation of patients with paroxysmal atrial fibrillation: Clinical analysis of more than 100 consecutive patients
30. Detection of atrial fibrillation by pacemakers and antiarrhythmic devices